Chen Shia-Chung, Lee Kuan-Hua, Chang Che-Wei, Hsu Tzu-Jeng, Feng Ching-Te
R&D Center for Smart Manufacturing, Chung Yuan Christian University, Taoyuan 32023, Taiwan.
R&D Center for Semiconductor Carrier, Chung Yuan Christian University, Taoyuan 32023, Taiwan.
Polymers (Basel). 2022 May 15;14(10):2017. doi: 10.3390/polym14102017.
Microcellular injection molding technology (MuCell) using supercritical fluid (SCF) as a foaming agent offers many advantages, such as material and energy savings, low cycle time, cost-effectiveness, and the dimensional stability of products. MuCell has attracted great attention for applications in the automotive, packaging, sporting goods, and electrical parts industries. In view of the environmental issues, the shoe industry, particularly for midsole parts, is also seriously considering using physical foaming to replace the chemical foaming process. MuCell is thus becoming one potential processing candidate. Thermoplastic polyurethane (TPU) is a common material for molding the outsole of shoes because of its outstanding properties such as hardness, abrasion resistance, and elasticity. Although many shoe manufacturers have tried applying Mucell processes to TPU midsoles, the main problem remaining to be overcome is the non-uniformity of the foaming cell size in the molded midsole. In this study, the MuCell process combined with gas counter pressure (GCP) technology and dynamic mold temperature control (DMTC) were carried out for TPU molding. The influence of various molding parameters including SCF dosage, injection speed, mold temperature, gas counter pressure, and gas holding time on the foaming cell size and the associated size distribution under a target weight reduction of 60% were investigated in detail. Compared with the conventional MuCell process, the implementation of GCP technology or DMTC led to significant improvement in foaming cell size reduction and size uniformity. Further improvement could be achieved by the simultaneous combination of GCP with DMT, and the resulting cell density was about fifty times higher. The successful possibility for the microcellular injection molding of TPU shoe midsoles is greatly enhanced.
使用超临界流体(SCF)作为发泡剂的微细胞注射成型技术(MuCell)具有许多优点,如节省材料和能源、周期时间短、成本效益高以及产品尺寸稳定性好。MuCell在汽车、包装、体育用品和电气部件行业的应用中备受关注。鉴于环境问题,制鞋行业,特别是中底部件,也在认真考虑使用物理发泡来取代化学发泡工艺。因此,MuCell正成为一种潜在的加工候选方法。热塑性聚氨酯(TPU)因其硬度、耐磨性和弹性等优异性能,是用于成型鞋底的常用材料。尽管许多鞋类制造商已尝试将MuCell工艺应用于TPU中底,但仍有待克服的主要问题是成型中底中发泡泡孔尺寸的不均匀性。在本研究中,将MuCell工艺与气体反压(GCP)技术和动态模具温度控制(DMTC)相结合用于TPU成型。详细研究了包括SCF用量、注射速度、模具温度、气体反压和保压时间等各种成型参数对目标减重60%下的发泡泡孔尺寸及其相关尺寸分布的影响。与传统的MuCell工艺相比,GCP技术或DMTC的实施导致发泡泡孔尺寸减小和尺寸均匀性有显著改善。通过GCP与DMT的同时结合可实现进一步改进,并且所得泡孔密度提高了约五十倍。TPU鞋中底微细胞注射成型的成功可能性大大提高。